Deletion of miR-146a enhances therapeutic protein restoration in model of dystrophin exon skipping

Duchenne muscular dystrophy (DMD) is a progressive muscle disease caused by the absence of dystrophin protein. One current DMD therapeutic strategy, exon skipping, produces a truncated dystrophin isoform using phosphorodiamidate morpholino oligomers (PMOs). However, the potential of exon skipping th...

Descripción completa

Detalles Bibliográficos
Autores principales: McCormack, Nikki M., Calabrese, Kelsey A., Sun, Christina M., Tully, Christopher B., Heier, Christopher R., Fiorillo, Alyson A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197665/
https://www.ncbi.nlm.nih.gov/pubmed/37214870
http://dx.doi.org/10.1101/2023.05.09.540042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197665/
https://www.ncbi.nlm.nih.gov/pubmed/37214870
http://dx.doi.org/10.1101/2023.05.09.540042

Ejemplares similares